{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:15:55Z","timestamp":1761178555798,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T00:00:00Z","timestamp":1668902400000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.canrad.2021.04.004","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T12:11:33Z","timestamp":1619525493000},"page":"801-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radioth\u00e9rapie du carcinome \u00e9pidermo\u00efde du larynx de stade pr\u00e9coce, \u00e9tage glottique\u00a0: int\u00e9r\u00eat de l\u2019hypofractionnement\u00a0?"],"prefix":"10.1016","volume":"25","author":[{"given":"M.","family":"Tonneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Matta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Mirabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-4189","authenticated-orcid":false,"given":"F.","family":"Crop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Lacornerie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Escande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Liem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.04.004_bib0285","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2021.04.004_bib0290","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1200\/JCO.2001.19.20.4029","article-title":"T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy","volume":"19","author":"Mendenhall","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0295","first-page":"CD002027","article-title":"Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer","volume":"2014","author":"Warner","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.canrad.2021.04.004_bib0300","doi-asserted-by":"crossref","first-page":"11900","DOI":"10.1038\/s41598-018-30218-x","article-title":"Comparison between transoral laser surgery and radiotherapy in the treatment of early glottic cancer: a systematic review and meta-analysis","volume":"8","author":"Guimar\u00e3es","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.canrad.2021.04.004_bib0305","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.rpor.2020.08.007","article-title":"Surgery versus radiotherapy: long-term outcomes of T1 glottic cancer","volume":"25","author":"Ferreira","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.canrad.2021.04.004_bib0310","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00005537-200301000-00013","article-title":"Quality of life, functional outcome, and costs of early glottic cancer","volume":"113","author":"Smith","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2021.04.004_bib0315","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1007\/s00405-020-06257-4","article-title":"Moderate hypofractionation for early laryngeal cancer improves local control with increased risk of mucositis: clarification","volume":"277","author":"Benson","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0320","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0360-3016(96)00578-0","article-title":"Impact of radiation therapy fraction size on local control of early glottic carcinoma","volume":"37","author":"Yu","year":"1997","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0325","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0360-3016(97)00284-8","article-title":"Influence of fraction size, total dose, and overall time on local control of T1\u2013T2 glottic carcinoma","volume":"39","author":"Le","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.04.004_bib0330","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1440-1673.2006.01559.x","article-title":"TN\/TN glottic carcinoma: a comparison of two fractionation schedules","volume":"50","author":"Short","year":"2006","journal-title":"Australas Radiol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0335","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3342\/ceo.2012.5.2.94","article-title":"Definitive radiation therapy for early glottic cancer: experience of two fractionation schedules","volume":"5","author":"Kim","year":"2012","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0340","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/COC.0b013e318256f5fd","article-title":"Long-term follow-up and pattern of failure for T1\u2013T2 glottic cancer after definitive radiation therapy","volume":"36","author":"Mourad","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0345","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/jrr\/rrs134","article-title":"Radiotherapy with fraction size of 2.25 Gy in T1-2 laryngeal and hypopharyngeal cancer","volume":"54","author":"Karasawa","year":"2013","journal-title":"J Radiat Res"},{"key":"10.1016\/j.canrad.2021.04.004_bib0350","doi-asserted-by":"crossref","first-page":"djx042","DOI":"10.1093\/jnci\/djx042","article-title":"Hypofractionated radiotherapy for patients with early-stage glottic cancer: patterns of care and survival","volume":"109","author":"Bledsoe","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2021.04.004_bib0355","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3857\/roj.2019.00143","article-title":"Hypofractionated radiotherapy for early glottic cancer: a retrospective interim analysis of a single-institution","volume":"37","author":"Lee","year":"2019","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.canrad.2021.04.004_bib0360","doi-asserted-by":"crossref","first-page":"102544","DOI":"10.1016\/j.amjoto.2020.102544","article-title":"Hypofractionated radiotherapy and surgery compared to standard radiotherapy in early glottic cancer","volume":"41","author":"Kim","year":"2020","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijrobp.2005.06.014","article-title":"Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time","volume":"64","author":"Yamazaki","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.04.004_bib0370","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/COC.0b013e3181a3194f","article-title":"Definitive radiotherapy for carcinoma in situ of the true vocal cords","volume":"33","author":"Sengupta","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0375","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.radonc.2013.09.016","article-title":"A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study","volume":"110","author":"Moon","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0380","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4103\/0019-509X.200677","article-title":"Accelerated versus conventional radiation fractionation in early-stage carcinoma larynx","volume":"53","author":"Alam","year":"2016","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.canrad.2021.04.004_bib0385","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/annonc\/mdy036","article-title":"Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study (JCOG0701)","volume":"29","author":"Kodaira","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0390","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12094-019-02118-7","article-title":"Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study","volume":"22","author":"Salas-Salas","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0395","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0167-8140(03)00059-8","article-title":"Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience","volume":"68","author":"Gowda","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0400","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1743-7563.2008.00216.x","article-title":"Hypofractionated versus standard fractionation radiotherapy in early glottic cancer: a retrospective review","volume":"4","author":"Gupta","year":"2008","journal-title":"Asia-Pacific J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0405","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2015.06.016","article-title":"Single vocal cord irradiation: image guided intensity modulated hypofractionated radiation therapy for T1a glottic cancer: early clinical results","volume":"93","author":"Al-Mamgani","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.04.004_bib0410","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13014-015-0505-6","article-title":"Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55 Gy in 20 fractions","volume":"10","author":"Ermi\u015f","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0415","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13014-017-0915-8","article-title":"Conventional fractionation should not be the standard of care for T2 glottic cancer","volume":"12","author":"Dixon","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0420","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.oraloncology.2017.07.013","article-title":"Patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United States","volume":"72","author":"Stokes","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0425","doi-asserted-by":"crossref","first-page":"e0172055","DOI":"10.1371\/journal.pone.0172055","article-title":"SBRT for early-stage glottic larynx cancer\u00a0\u2013\u00a0Initial clinical outcomes from a phase I clinical trial","volume":"12","author":"Schwartz","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.canrad.2021.04.004_bib0430","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2019.03.010","article-title":"Phase 1 fractional dose-escalation study of equipotent stereotactic radiation therapy regimens for early-stage glottic larynx cancer","volume":"105","author":"Sher","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.04.004_bib0435","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1002\/lary.27226","article-title":"Study design and early result of a phase I study of SABR for early-stage glottic cancer","volume":"128","author":"Yu","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2021.04.004_bib0440","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2019.03.011","article-title":"Early closure of a phase 1 Clinical Trial for SABR in early-stage glottic cancer","volume":"105","author":"Kang","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.04.004_bib0445","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0360-3016(88)90220-9","article-title":"T1\u2013T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications","volume":"15","author":"Mendenhall","year":"1988","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0450","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1080\/02841860310013490","article-title":"Extracranial stereotactic radioablation physical principles","volume":"42","author":"Papie\u017c","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0455","first-page":"4155","article-title":"Exclusive radiotherapy for early-stage glottic cancer: a single-institution retrospective analysis with a focus on voice quality","volume":"35","author":"Potenza","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canrad.2021.04.004_bib0460","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1288\/00005537-198107000-00014","article-title":"Treatment of carcinoma of the vocal cord. A review of 20 years experience","volume":"91","author":"Woodhouse","year":"1981","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2021.04.004_bib0465","first-page":"150","article-title":"The role of radiation therapy in laryngeal cancer","volume":"40","author":"Mendenhall","year":"1990","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2021.04.004_bib0470","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/1053-4296(92)90004-5","article-title":"Radiotherapy alone for moderately advanced laryngeal cancer (T2\u2013T3)","volume":"2","author":"Parsons","year":"1992","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0475","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijrobp.2015.07.2284","article-title":"Radiation therapy intensification for solid tumors: a systematic review of randomized trials","volume":"93","author":"Yamoah","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0480","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0360-3016(02)03938-X","article-title":"Results of radiotherapy for T2N0 glottic carcinoma: does the \u201c2\u201d stand for twice-daily treatment?","volume":"55","author":"Garden","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.04.004_bib0485","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0360-3016(98)00226-0","article-title":"The impact of treatment time and smoking on local control and complications in T1 glottic cancer","volume":"42","author":"van der Voet","year":"1998","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0490","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jnci\/djx229","article-title":"RE: hypofractionated radiotherapy for patients with early-stage glottic cancer: patterns of care and survival","volume":"110","author":"Overgaard","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2021.04.004_bib0495","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2019.04.007","article-title":"Altered-fractionation radiotherapy improves local control in early-stage glottic carcinoma: a systematic review and meta-analysis of 1762 patients","volume":"93","author":"Sapienza","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0500","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.oraloncology.2016.10.013","article-title":"Risk factors for radiation failure in early-stage glottic carcinoma: a systematic review and meta-analysis","volume":"62","author":"Eskiizmir","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0505","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/14737140.2019.1626234","article-title":"An update on advanced dual-energy CT for head and neck cancer imaging","volume":"19","author":"Forghani","year":"2019","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.canrad.2021.04.004_bib0510","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0002-9610(05)80104-7","article-title":"Surgical salvage treatment of T1\/T2 glottic carcinoma after failure of radiotherapy","volume":"168","author":"Schwaab","year":"1994","journal-title":"Am J Surg"},{"key":"10.1016\/j.canrad.2021.04.004_bib0515","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0360-3016(92)90742-Z","article-title":"The predictive role of bioeffect dose models in radiation-induced late effects in glottic cancers","volume":"23","author":"Deore","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.04.004_bib0520","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-8140(97)00154-0","article-title":"Objective evaluation of the quality of voice following radiation therapy for T1 glottic cancer","volume":"45","author":"Aref","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0525","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.radonc.2008.09.016","article-title":"Factors affecting the quality of voice in the early glottic cancer treated with radiotherapy","volume":"90","author":"Agarwal","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0530","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3389\/fonc.2020.01447","article-title":"Is single cord irradiation going to be a new standard for T1a glottic carcinoma?","volume":"10","author":"Kocak Uzel","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0535","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2008.01.006","article-title":"Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1\/T2 larynx cancer","volume":"87","author":"Kazi","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0540","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/1097-0142(19820215)49:4<655::AID-CNCR2820490409>3.0.CO;2-I","article-title":"The significance of laryngeal edema following radiotherapy of carcinoma of the vocal cord","volume":"49","author":"Fu","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2021.04.004_bib0545","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ijrobp.2007.01.010","article-title":"Dosimetric predictors of laryngeal edema","volume":"68","author":"Sanguineti","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.04.004_bib0550","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ijrobp.2016.02.049","article-title":"Risk of severe toxicity according to site of recurrence in patients treated with stereotactic body radiation therapy for recurrent head and neck cancer","volume":"95","author":"Ling","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.04.004_bib0555","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2020.08.027","article-title":"Surface guided motion management in glottic larynx stereotactic body radiation therapy","volume":"153","author":"Zhao","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.04.004_bib0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.radonc.2008.05.016","article-title":"Four-dimensional CT analysis of vocal cords mobility for highly focused single vocal cord irradiation","volume":"89","author":"Osman","year":"2008","journal-title":"Radiother Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:33:41Z","timestamp":1761136421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1278321821000561"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.04.004","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioth\u00e9rapie du carcinome \u00e9pidermo\u00efde du larynx de stade pr\u00e9coce, \u00e9tage glottique\u00a0: int\u00e9r\u00eat de l\u2019hypofractionnement\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}